In a victory for those advocating treating COVID-19 with ivermectin or hydroxychloroquine, Republican Doug Peterson, Attorney General for the State of Nebraska, indicated he would not penalize or seek disciplinary action against physicians prescribing the off-label drugs as part of a COVID-19 treatment plan.
The October 14th ruling from the Attorney General follows a request from Dannette Smith, the CEO of Nebraska’s Department of Health and Human Services. The Epoch Times reports that Smith requested a ruling on the use of ivermectin and hydroxychloroquine, asking if physicians prescribing them would be “deemed unlawful or otherwise subject to discipline.”
The Attorney General’s report includes this summary statement: “Based on the evidence that currently exists, the mere fact of prescribing ivermectin or hydroxychloroquine for COVID-19 will not result in our office filing disciplinary actions.”
The report does not advocate for the use of the medications, but it does not prevent physicians from treating their patients with them. “Allowing physicians to consider these early treatments,” the report reads, “will free them to evaluate additional tools that could save lives, keep patients out of the hospital, and provide relief for our already strained health care system.”
The report also mentions the controversy concerning these drugs and a deliberate misinformation campaign to discredit them.
The ruling will be hailed by many who want to see the widespread use of the medications in the United States rather than mandated vaccines, a practice used in India with great success.
Unusual position statements by key regulatory and medical agencies regarding the use of hydroxychloroquine and ivermectin have contributed to vaccine hesitancy.
A list of controversial statements regarding the drugs was included in an article in the Epoch Times. They include the following:
a false study discrediting hydroxychloroquine published in the Lancet Medical Journal, which was later retracted;
censorship of social media posts by physicians advocating for use of the medications; and
warnings by the World Health Organization and Center for Disease Control, despite the medications being part of recommended treatment plans for other diseases.
While medical associations and regulators around the world currently recommend against the use of ivermectin outside of clinical trials, several groups, including the Front Line COVID-19 Critical Care Alliance and the British Ivermectin Recommendation Development Group, have encouraged use of the drugs.
The Epoch Times article notes that there are 45 peer-reviewed studies and a total of 63 studies on the treatment of COVID-19 with ivermectin.
Scroll down to leave a comment and share your thoughts.
